The effects of OC000459 on nasal Th2 cytokine release, eosinophil responses, and nasal symptoms after nasal allergen challenge (NAC) with timothy grass pollen in subjects with allergic rhinitis out of season

Trial Profile

The effects of OC000459 on nasal Th2 cytokine release, eosinophil responses, and nasal symptoms after nasal allergen challenge (NAC) with timothy grass pollen in subjects with allergic rhinitis out of season

Completed
Phase of Trial: Phase I

Latest Information Update: 07 Oct 2006

At a glance

  • Drugs OC 459 (Primary)
  • Indications Allergic rhinitis
  • Focus Biomarker; Pharmacodynamics
  • Most Recent Events

    • 07 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top